INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis
NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
Taking everything into account, INFU scores 6 out of 10 in our fundamental rating. INFU was compared to 102 industry peers in the Health Care Providers & Services industry. INFU scores excellent on profitability, but there are some minor concerns on its financial health. INFU is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes INFU very considerable for growth investing!
1. Profitability
1.1 Basic Checks
INFU had positive earnings in the past year.
In the past year INFU had a positive cash flow from operations.
Each year in the past 5 years INFU has been profitable.
Each year in the past 5 years INFU had a positive operating cash flow.
1.2 Ratios
INFU's Return On Assets of 3.06% is fine compared to the rest of the industry. INFU outperforms 64.71% of its industry peers.
Looking at the Return On Equity, with a value of 5.78%, INFU is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
The Return On Invested Capital of INFU (7.47%) is better than 72.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for INFU is significantly below the industry average of 9.62%.
The last Return On Invested Capital (7.47%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROIC | 7.47% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
INFU has a Profit Margin of 2.32%. This is in the better half of the industry: INFU outperforms 62.75% of its industry peers.
In the last couple of years the Profit Margin of INFU has remained more or less at the same level.
INFU's Operating Margin of 6.07% is fine compared to the rest of the industry. INFU outperforms 63.73% of its industry peers.
In the last couple of years the Operating Margin of INFU has grown nicely.
With a decent Gross Margin value of 53.13%, INFU is doing good in the industry, outperforming 78.43% of the companies in the same industry.
INFU's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
INFU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
INFU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, INFU has more shares outstanding
INFU has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.56 indicates that INFU is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of INFU (2.56) is comparable to the rest of the industry.
The Debt to FCF ratio of INFU is 12.54, which is on the high side as it means it would take INFU, 12.54 years of fcf income to pay off all of its debts.
INFU has a Debt to FCF ratio (12.54) which is in line with its industry peers.
INFU has a Debt/Equity ratio of 0.52. This is a neutral value indicating INFU is somewhat dependend on debt financing.
INFU has a better Debt to Equity ratio (0.52) than 60.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Altman-Z | 2.56 |
ROIC/WACC0.89
WACC8.39%
2.3 Liquidity
A Current Ratio of 2.21 indicates that INFU has no problem at all paying its short term obligations.
INFU has a better Current ratio (2.21) than 77.45% of its industry peers.
A Quick Ratio of 1.83 indicates that INFU should not have too much problems paying its short term obligations.
INFU has a better Quick ratio (1.83) than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 6900.00% over the past year.
INFU shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.59% yearly.
The Revenue has been growing slightly by 7.98% in the past year.
Measured over the past years, INFU shows a quite strong growth in Revenue. The Revenue has been growing by 10.70% on average per year.
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
3.2 Future
The Earnings Per Share is expected to grow by 84.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, INFU will show a quite strong growth in Revenue. The Revenue will grow by 8.03% on average per year.
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 43.36 indicates a quite expensive valuation of INFU.
INFU's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.60. INFU is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 17.78, INFU is valued on the expensive side.
Based on the Price/Forward Earnings ratio, INFU is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
INFU is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.36 | ||
| Fwd PE | 17.78 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INFU is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as INFU.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.63 | ||
| EV/EBITDA | 7.29 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INFU may justify a higher PE ratio.
INFU's earnings are expected to grow with 84.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)4.1
EPS Next 2Y84.76%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for INFU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSEARCA:INFU (6/13/2025, 10:45:07 AM)
6.07
-0.03 (-0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.82%
Inst Owner Change-0.34%
Ins Owners3.62%
Ins Owner Change0.69%
Market Cap127.35M
Analysts84
Price Target13.9 (129%)
Short Float %2.04%
Short Ratio2.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-48.06%
Max EPS beat(2)75.49%
EPS beat(4)2
Avg EPS beat(4)7.91%
Min EPS beat(4)-48.06%
Max EPS beat(4)75.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-4.92%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)6
Avg Revenue beat(12)-0.71%
Revenue beat(16)7
Avg Revenue beat(16)-1.97%
PT rev (1m)-3.54%
PT rev (3m)-3.54%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)-20.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-35.4%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.36 | ||
| Fwd PE | 17.78 | ||
| P/S | 0.93 | ||
| P/FCF | 55.63 | ||
| P/OCF | 5.83 | ||
| P/B | 2.31 | ||
| P/tB | 2.82 | ||
| EV/EBITDA | 7.29 |
EPS(TTM)0.14
EY2.31%
EPS(NY)0.34
Fwd EY5.62%
FCF(TTM)0.11
FCFY1.8%
OCF(TTM)1.04
OCFY17.17%
SpS6.56
BVpS2.63
TBVpS2.16
PEG (NY)0.54
PEG (5Y)4.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROCE | 9.46% | ||
| ROIC | 7.47% | ||
| ROICexc | 7.6% | ||
| ROICexgc | 8.58% | ||
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% | ||
| FCFM | 1.66% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Debt/EBITDA | 1.35 | ||
| Cap/Depr | 151.51% | ||
| Cap/Sales | 14.23% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.77% | ||
| Profit Quality | 71.76% | ||
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.56 |
F-Score9
WACC8.39%
ROIC/WACC0.89
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y149.37%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year297.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.23%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y64.52%
OCF growth 3Y3.76%
OCF growth 5Y8.08%